Perrigo Company plc (NYSE:PRGO) Shares Purchased by D. E. Shaw & Co. Inc.

D. E. Shaw & Co. Inc. increased its holdings in shares of Perrigo Company plc (NYSE:PRGO) by 37.6% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,044,574 shares of the company’s stock after purchasing an additional 285,384 shares during the period. D. E. Shaw & Co. Inc.’s holdings in Perrigo were worth $42,274,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of PRGO. Price T Rowe Associates Inc. MD boosted its stake in Perrigo by 31.9% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 23,192,628 shares of the company’s stock worth $938,606,000 after purchasing an additional 5,606,007 shares during the period. Arrowstreet Capital Limited Partnership boosted its stake in Perrigo by 692.7% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 1,334,738 shares of the company’s stock worth $54,017,000 after purchasing an additional 1,166,360 shares during the period. Norges Bank acquired a new stake in Perrigo during the 4th quarter worth $48,130,000. Goldman Sachs Group Inc. boosted its stake in Perrigo by 263.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,474,315 shares of the company’s stock worth $59,665,000 after purchasing an additional 1,068,658 shares during the period. Finally, JPMorgan Chase & Co. raised its position in Perrigo by 148.2% during the 1st quarter. JPMorgan Chase & Co. now owns 863,705 shares of the company’s stock worth $34,953,000 after buying an additional 515,777 shares during the last quarter. Hedge funds and other institutional investors own 84.34% of the company’s stock.

Shares of Perrigo stock opened at $45.75 on Thursday. The stock has a market cap of $6.11 billion, a P/E ratio of -27.09 and a beta of 1.19. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.32 and a current ratio of 3.10. Perrigo Company plc has a one year low of $38.20 and a one year high of $57.17. The stock’s fifty day moving average price is $46.48.

Perrigo (NYSE:PRGO) last announced its quarterly earnings data on Monday, May 10th. The company reported $0.50 EPS for the quarter, missing the Zacks’ consensus estimate of $0.57 by ($0.07). The firm had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Perrigo had a positive return on equity of 8.06% and a negative net margin of 4.88%. The firm’s quarterly revenue was down 6.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS. As a group, equities analysts anticipate that Perrigo Company plc will post 2.59 EPS for the current year.

Separately, Royal Bank of Canada assumed coverage on shares of Perrigo in a research report on Wednesday, April 7th. They set a “sector perform” rating and a $51.00 price objective for the company. Three analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $52.00.

Perrigo Profile

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments.

Further Reading: How to Use the New Google Finance Tool

Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO).

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.